Image

The Fourth Left Atrial Appendage Occlusion Study

Join our study on heart health and left atrial appendage occlusion!

Recruiting
18 years and older
All
Phase N/A

LAAOS-4 is a research study to see if a procedure called left atrial appendage occlusion can prevent strokes in people with atrial fibrillation (a condition where the heart beats irregularly). This procedure uses a catheter, which is a thin tube inserted into the body, to block a small part of the heart called the left atrial appendage. The study will include people who are already taking oral anticoagulants (medicines that help prevent blood clots) but still have a high risk of stroke. To join, participants must be 18 or older, have a history of atrial fibrillation, and be on anticoagulants for at least 90 days before starting the study.

  • Study Length: Participants need to be on anticoagulants throughout the study.
  • Eligibility: High stroke risk, age 18+, and current anticoagulant use.
  • Risks: Must not have a history of certain heart procedures or thrombus in the heart.
Study details
    Atrial Fibrillation
    Stroke
    Ischemic
    Systemic Embolism

NCT05963698

Hamilton Health Sciences Corporation

12 September 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.